Buy One Get One free -Llimited Time Offer X
Gudcef CV Oral Suspension is a commercial drug that is prescribed in the form of Syrup. Gudcef CV Oral Suspension also has some secondary and off-label uses. These are listed below.
The correct dosage of Gudcef CV Oral Suspension depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Gudcef CV Oral Suspension can also lead to other problems, which have been listed below. Usually, these side effects of Gudcef CV Oral Suspension go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Gudcef CV Oral Suspension's effect during pregnancy is Mild and Moderate while nursing. In addition, Gudcef CV Oral Suspension's effects on the liver, heart and kidney are discussed below in the Gudcef CV Oral Suspension related warnings section.
Gudcef CV Oral Suspension is not recommended if you suffer from certain medical conditions as it can have adverse effects. Jaundice are examples of such conditions. Some other conditions that can be affected by Gudcef CV Oral Suspension are listed in the contraindications section below.
Drug interactions for Gudcef CV Oral Suspension have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Gudcef CV Oral Suspension is safe while driving, and is is addictive in nature.
Gudcef CV Oral Suspension is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Gudcef CV Oral Suspension safe for pregnant women?
Gudcef CV has little to no side effects in pregnant women.
Is the use of Gudcef CV Oral Suspension safe during breastfeeding?
Gudcef CV may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Gudcef CV, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Gudcef CV.
What is the effect of Gudcef CV Oral Suspension on the Kidneys?
Kidney can be affected by Gudcef CV. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Gudcef CV Oral Suspension on the Liver?
There may be an adverse effect on the liver after taking Gudcef CV. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Gudcef CV Oral Suspension on the Heart?
Gudcef CV has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Gudcef CV Oral Suspension unless your doctor advises you to do so -
Is this Gudcef CV Oral Suspension habit forming or addictive?
No, you will not get addicted to Gudcef CV Oral Suspension.
Interaction between Food and Gudcef CV Oral Suspension
It is safe to take Gudcef CV Oral Suspension with food.
Interaction between Alcohol and Gudcef CV Oral Suspension
No research has been done on this till date. Therefore, it is not known what the effect of taking Gudcef CV Oral Suspension with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311